Prostate Cancer Clinical Trial
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.
Male, 35-85 years old
Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.)
Patients who present for the evaluation of a palpable nodule or induration on prostate exam
Patients who meet the requirements of Group 1, 2, or 3 of the protocol
Patient < 35 or > 85 years of age
Concurrent eye infection or trauma, including active conjunctivitis
Abnormal production of tears (too much or too little)
Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment
Atypia on prostate biopsy report
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Little Rock Arkansas, 72205, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.